Post-earnings recap
Reported
Mon, Mar 16, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a loss of $0.21 per share for Q4 2019, but did not provide revenue figures or any guidance. The stock reacted negatively, dropping nearly 24%, likely reflecting investor disappointment over the lack of financial clarity and guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.21 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.